Cancer, Ovarian Completed Phase 2 Trials for Fondaparinux (DB00569)

Also known as: Cancer of the Ovary / Ovarian Cancer / Ovary Cancer / Cancer of Ovary / Ca ovary / Malignant tumor of ovary / Malignant neoplasm of ovary / Ovarian cancer NOS

DBCOND0063542 (Cancer, Ovarian)Completed2 IdentifierTitlePurposeDrugs
NCT00381888Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic CancerTreatment